Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease

Nobuharu Tamaki; Mayu Higuchi; Masayuki Kurosaki; Rohit Loomba; Namiki Izumi; MRCH Liver Study Group

doi:10.1016/j.cgh.2021.07.021

Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease

Clin Gastroenterol Hepatol. 2022 May;20(5):1171-1173.e2. doi: 10.1016/j.cgh.2021.07.021. Epub 2021 Jul 16.

Authors

Nobuharu Tamaki¹, Mayu Higuchi², Masayuki Kurosaki², Rohit Loomba³, Namiki Izumi⁴; MRCH Liver Study Group

Collaborators

MRCH Liver Study Group:
Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura

Affiliations

¹ Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan; NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, La Jolla, California.
² Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
³ NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, La Jolla, California.
⁴ Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan. Electronic address: izumi012@musashino.jrc.or.jp.

Abstract

Nonalcoholic fatty liver disease (NAFLD) has affected more than one-fourth of the global population, thus emerging as a worldwide health and economic burden.¹ The common causes of death in patients with NAFLD include cardiovascular disease (CVD), decompensation, and hepatocellular carcinoma (HCC). However, identifying the risk of these complications in patients with NAFLD remains an unmet need in clinical practice.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Letter

MeSH terms

Carcinoma, Hepatocellular* / epidemiology
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / etiology
Humans
Liver Cirrhosis / complications
Liver Neoplasms* / epidemiology
Non-alcoholic Fatty Liver Disease* / pathology

Abstract

Publication types

MeSH terms

Grants and funding